FGF23 and heart rhythm in dialysis patients
Part of Heart & circulation clinical trials.
This study looks at whether a blood protein called FGF23 is linked to irregular heartbeats in people on long-term hemodialysis (kidney dialysis). It may help doctors better predict heart risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can give your consent to participate
- You have been on maintenance hemodialysis for at least 3 months
- You do not have a history of atrial fibrillation (a type of irregular heartbeat) or a pacemaker
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the electrical activity of the heart (which controls your heartbeat) changes during and after your regular dialysis sessions. The goal is to see if dialysis affects your heart's rhythm, which can help doctors monitor and prevent heart problems in people on dialysis.
This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.
This study looks at how well the heart and blood vessels work together during dialysis sessions. It may help doctors predict future heart problems so they can better care for people on dialysis.
This study is testing a new monitoring tool to keep an eye on the health of the fistula used for dialysis. It aims to catch problems early so you can avoid complications.
This study looks at a blood hormone called FGF23 and whether it is linked to heart (cardiovascular) problems in people with anemia. It also compares people with anemia who do and do not have chronic kidney disease, which may help researchers understand risk and targets.
This study looks at how a protein called FGF23, which helps control minerals in your body, changes as kidney disease progresses. By understanding this, doctors may find better ways to manage kidney disease.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.